Sfoglia per Autore  

Opzioni
Mostrati risultati da 1 a 20 di 80
Titolo Data di pubblicazione Autori File
Monoclonal antibodies-based treatment in gastric cancer: current status and future perspectives 1-gen-2016 ROVIELLO, GIANDOMENICOGENERALI, DANIELE +
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for treatment of ovarian cancer 1-gen-2016 ROVIELLO, GIANDOMENICOGENERALI, DANIELE +
No Advantage in Survival With Targeted Therapies as Maintenance in Patients With Limited and Extensive-Stage Small Cell Lung Cancer: A Literature-Based Meta-Analysis of Randomized Trials 1-gen-2016 ROVIELLO, GIANDOMENICOGENERALI, DANIELE +
Apatinib for the treatment of gastric cancer 1-gen-2016 ROVIELLO, GIANDOMENICOGENERALI, DANIELE +
Incidence and relative risk of adverse events of special interest in patients with castration resistant prostate cancer treated with CYP-17 inhibitors: A meta-analysis of published trials 1-gen-2016 ROVIELLO, GIANDOMENICODANESI, ROMANOGENERALI, DANIELE +
Re: Karim Fizazi, Kim N. Chi, Johann S. de Bono, et al. Low Incidence of Corticosteroid-associated Adverse Events on Long-term Exposure to Low-dose Prednisone Given with Abiraterone Acetate to Patients with Metastatic Castration-resistant Prostate Cancer. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2016.02.035: Corticosteroid-associated Adverse Events in Elderly Patients 1-gen-2016 ROVIELLO, GIANDOMENICOGENERALI, DANIELE +
Is it time for everolimus-based combination in castration-resistant prostate cancer? 1-gen-2016 ROVIELLO, GIANDOMENICOGENERALI, DANIELE +
New molecular therapies in patients with advanced Hepatocellular Cancer in second line of treatment: Is a real defeat?: Results from a literature based meta-analysis of randomized trials 1-gen-2016 ROVIELLO, GIANDOMENICOGENERALI, DANIELE +
Role of targeted agents in neuroendocrine tumors: Results from a meta-analysis 1-gen-2016 ROVIELLO, GIANDOMENICOGENERALI, DANIELE +
Is the Gleason score the driver for the treatment decision-making of patients with castration-resistant prostate cancer in the new era of the anti-androgenic therapies? 1-gen-2016 ROVIELLO, GIANDOMENICOGENERALI, DANIELE
A Phase II study of olaparib in breast cancer patients: Biological evaluation from a 'window of opportunity' trial 1-gen-2016 ROVIELLO, GIANDOMENICOGENERALI, DANIELE +
A Phase Ib Open-Label Study to Assess the Safety and Tolerability of Everolimus in Combination with Eribulin in Triple-Negative Breast Cancers 1-gen-2016 ROVIELLO, GIANDOMENICOGENERALI, DANIELE +
Expanding treatment options for metastatic gastric cancer 1-gen-2016 ROVIELLO, GIANDOMENICOGENERALI, DANIELE +
Neoadjuvant chemotherapy and radical radiotherapy associated with cetuximab for laryngeal cancer in a pancreas and renal recipient 1-gen-2016 ROVIELLO, GIANDOMENICOGENERALI, DANIELE +
Role of the novel generation of androgen receptor pathway targeted agents in the management of castration-resistant prostate cancer: A literature based meta-analysis of randomized trials 1-gen-2016 ROVIELLO, GIANDOMENICOGENERALI, DANIELE +
Apatinib: A novel receptor tyrosine kinase inhibitor for the treatment of gastric cancer 1-gen-2016 ROVIELLO, GIANDOMENICOGENERALI, DANIELE +
Epirubicin-based compared with docetaxel-based chemotherapy for advanced gastric carcinoma: A systematic review and meta-analysis 1-gen-2016 ROVIELLO, GIANDOMENICOGENERALI, DANIELE +
Targeting the androgenic pathway in elderly patients with castration-resistant prostate cancer: A meta-analysis of randomized trials 1-gen-2016 ROVIELLO, GIANDOMENICOGENERALI, DANIELE +
Is there a place for bevacizumab in patients with extensive-stage small cell lung cancer? 1-gen-2016 ROVIELLO, GIANDOMENICOGENERALI, DANIELE
Surgical management of advanced gastric cancer: An evolving issue 1-gen-2016 ROVIELLO, GIANDOMENICOGENERALI, DANIELE +
Mostrati risultati da 1 a 20 di 80
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile